Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Ambey Laboratories IPO
Price Band
₹65.0–68.0
Issue Size
₹44.68 Cr
Lot Size
2,000 shares
Min Investment
₹136,000
GMP
+₹28.0 (41.18%)
Issue Price
₹68.0
Subject to Sauda
₹42600
Paid only if allotted
Ambey Laboratories IPO AI Summary
- Ambey Laboratories IPO is listed on NSE SME in the Pesticides & Agrochemicals sector.
- Price band: ₹65.0–₹68.0 per share, lot size 2,000 shares (min. investment ₹136,000).
- Subscription window: 04 Jul–08 Jul 2024, listing on 11 Jul 2024.
- Current GMP is +₹28.0 (41.18%), an estimated listing price of ₹96 — unofficial and can change daily.
Ambey Laboratories is an established player in the agrochemical sector with a range of products and a solid customer base. The upcoming IPO aims to raise funds for working capital and general corporate purposes, with a competitive P/E ratio compared to its peers.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Ambey Laboratories IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 08 Jul 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Ambey Laboratories IPO Grey Market Premium (GMP) Today
GMP
+₹28.0
GMP %
+41.18%
Est. Listing
₹96.0
Updated: 25 Jul 2026 14:05
About the Company
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades. The company manufactures and supplies 2,4-D base chemicals. The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation. The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd: 2,4-D Acid 98% TC 2,4-D Sodium 95% SP 2,4-D Amine 866 | 720 | 480g/l SL 2,4-D Ethyl Hexyl Ester 96% TC 2,4-D Ethyl Ester 96% TC Chlorpyriphos 97%TC / 20%EC / 50%EC Thiamethoxam 96%TC / 25%WG / 75%SG Pretilachlor 95%TC / 50%EC / 37%EW Metribuzin 97%TC / 70%WS Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC Metalaxyl 98%TC / 35%WS As of October 31, 2023 the company employs 220 people in various departments.
Company Financials (₹ Cr)
As of 2024-01-31
| Period Ended | 31 Jan 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 86.21 | 57.62 | 55.93 | 44.62 |
| Total Income | 100.44 | 107.43 | 85.11 | 82.42 |
| Profit After Tax | 6.08 | 4.57 | 3.57 | 10.34 |
| NET Worth | 34.31 | 23.64 | 19.07 | -7.86 |
| Reserves and Surplus | 15.62 | 5.89 | 1.32 | -12.76 |
| Total Borrowing | 20.05 | 13.65 | 18.05 | 32.93 |
Key Ratios
EPS
₹2.44
NAV
₹18.98
ROE
20.80%
ROCE
13.14%
RoNW
20.80%
P/B Value
3.58
P/E Ratio
27.81
Market Cap
₹171.64 Cr
PAT Margin
6.01%
Debt/Equity
0.58
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Meghmani Organics Ltd. | 65.11 | 15.11% | 63.21 | 9.85 | 9.85 |
| Atul Ltd | 1555.42 | 12.03% | 46.9 | 187.05 | 187.05 |
| Ambey Laboratories Limited This IPO | 13.32 | 19.33% | — | 2.57 | 2.57 |
Promoters
Archit Gupta, Arpit Gupta, Sarina Gupta and Rishita Gupta
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 To meet out the Working Capital requirements 30.93 2 To meet out the General Corporate Purposes 9.12 3 Issue Expenses 2.50
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹85.11 Cr in the year ending 31 Mar 2022, increasing to ₹107.43 Cr by 31 Mar 2023. However, it slightly decreased to ₹100.44 Cr by 31 Jan 2024, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹3.57 Cr in the year ending 31 Mar 2022, rising to ₹4.57 Cr by 31 Mar 2023. This figure increased further to ₹6.08 Cr by 31 Jan 2024, though this is a 9-month figure, not a full year, so isn't directly comparable.
Valuation
Ambey Laboratories has an EPS of ₹2.57, implying a P/E ratio of 27.81 at the issue price. In comparison, its peers have P/E ratios ranging from 46.9 to 63.21.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests that the IPO may list at a higher price than its issue price.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. It's important to consider the company's fundamentals and market conditions.
Who May Want to Wait
Those who prefer stable investments with lower risk may want to avoid IPOs, as they can be subject to significant price fluctuations in the short term.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when an IPO lists at a higher price than the issue price. However, these gains are not guaranteed and can be influenced by market conditions and investor sentiment on the listing day.
This evaluation is generated from Ambey Laboratories's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Ambey Laboratories IPO GMP today?
Ambey Laboratories IPO GMP today is +₹28.0 (41.18%), indicating an estimated listing price of ₹96. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Ambey Laboratories IPO?
The price band of Ambey Laboratories IPO is ₹65.0–₹68.0 per share.
When does Ambey Laboratories IPO open and close?
Ambey Laboratories IPO opens on 04 July 2024 and closes on 08 July 2024.
When does Ambey Laboratories IPO list on the stock exchange?
Ambey Laboratories IPO listed on 11 July 2024 at ₹96.0.
What is the lot size for Ambey Laboratories IPO?
The lot size for Ambey Laboratories IPO is 2000 shares, requiring a minimum investment of ₹136,000.
What is the price band for the IPO?
The price band for the IPO is ₹65.0 to ₹68.0.
What is the minimum investment required?
The minimum investment required is ₹136,000, which corresponds to a lot size of 2000 shares.
When does the IPO open and close?
The IPO opens on July 4, 2024, and closes on July 8, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of the IPO based on unofficial trading.
What is the listing date for the IPO?
The listing date for the IPO is July 11, 2024.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
04 Jul 2024
Close
08 Jul 2024
Allotment
09 Jul 2024
Listing
11 Jul 2024
Similar IPOs in Pesticides & Agrochemicals
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Ambey Laboratories?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.